PO-1047 Prospective evaluation of 167 brain metastases in Indian patients treated with robotic radiosurgery

2021 ◽  
Vol 161 ◽  
pp. S872-S873
Author(s):  
S. K ◽  
R. Kamath ◽  
A. Gupte ◽  
A. Sasidharan ◽  
P. K U ◽  
...  
2021 ◽  
Vol 161 ◽  
pp. S1242-S1243
Author(s):  
R. Kamath ◽  
S. K ◽  
A. Gupte ◽  
Y. Sreenija ◽  
P. K U ◽  
...  

2017 ◽  
Vol 3 (2) ◽  
pp. 151-154
Author(s):  
Daniela Schmitt ◽  
Rami El Shafie ◽  
Sebastian Klüter ◽  
Nathalie Arians ◽  
Kai Schubert ◽  
...  

AbstractTo evaluate the possible range of application of the new InCise2 MLC for the CyberKnife M6 system in brain radiosurgery, a plan comparison was made for 10 brain metastases sized between 1.5 and 9cm3 in 10 patients treated in a single fraction each. The target volumes consist of a PTV derived by expanding the GTV by 1mm and were chosen to have diversity in the cohort regarding regularity of shape, location and the structures needed to be blocked for beam transmission in the vicinity. For each case, two treatment plans were optimized: one using the MLC and one using the IRIS-collimator providing variable circular fields. Plan re-quirements were: dose prescription to the 70% isodose line (18 or 20Gy), 100% GTV coverage, ≥98% PTV coverage, undisturbed central high dose region (95% of maximum dose) and a conformity index as low as possible. Plan com-parison parameters were: conformity index (CI), high-dose gradient index (GIH), low-dose gradient index (GIL), total number of monitor units (MU) and expected treatment time (TT). For all cases, clinically acceptable plans could be gen-erated with the following results (mean±SD) for CI, GIH, GIL, MU and TT, respectively for the MLC plans: 1.09±0.03, 2.77±0.26, 2.61±0.08, 4514±830MU and 27±5min and for the IRIS plans: 1.05±0.01, 3.00±0.35, 2.46±0.08, 8557±1335MU and 42±7min. In summary, the MLC plans were on average less conformal and had a shallower dose gradient in the low dose region, but a steeper dose gradient in the high dose region. This is accompanied by a smaller vol-ume receiving 10Gy. A plan by plan comparison shows that usage of the MLC can spare about one half of the MUs and one third of treatment time. From these experiences and results suggestions for MLC planning strategy can be de-duced.


2016 ◽  
Vol 7 (3) ◽  
pp. 219-225
Author(s):  
Harvinder Singh Pahwa ◽  
◽  
Jitendra Kumar Kushwaha ◽  
Awanish Kumar ◽  
Saumya Singh ◽  
...  

2010 ◽  
Vol 49 (3) ◽  
pp. 382-388 ◽  
Author(s):  
Katarzyna Komosinska ◽  
Lucyna Kepka ◽  
Anna Niwinska ◽  
Lucyna Pietrzak ◽  
Marek Wierzchowski ◽  
...  

2016 ◽  
Vol 39 (3) ◽  
pp. 495-504 ◽  
Author(s):  
Antonio Pontoriero ◽  
Alfredo Conti ◽  
Giuseppe Iatì ◽  
Stefania Mondello ◽  
Dario Aiello ◽  
...  

2012 ◽  
Vol 30 (34_suppl) ◽  
pp. 17-17
Author(s):  
Jeffrey Noah Greenspoon ◽  
Waseem Sharieff ◽  
Anthony Whitton ◽  
Timothy Joseph Whelan ◽  
Jim R. Wright ◽  
...  

17 Background: With the emergence of radiosurgery as a new radiotheraputic technique, health care decision makers are required to incorporate community need, cost and patient preferences when allocating radiosurgery resources. Conventional patient utility measures would not reflect short term preferences and would therefore not inform decision makers when allocating radiosurgery treatment units. The goal of this article is to demonstrate the feasibility of cost-benefit analysis to elicit the yearly net monetary benefit of robotic radiosurgery. Methods: To calculate the yearly incremental cost of robotic radiosurgery as compared to fixed-gantry radiosurgery we used direct local cost data. We assumed a standard 10 year replacement and 5% amortization rate. Decision boards summarizing the clinical scenario of brain metastases and the difference between robotic and fixed-gantry radiosurgery in terms of immobilization, comfort and treatment time were then presented to a sample of 18 participants. Participants who preferred robotic radiosurgery were randomly assigned to either a low ($1) or high ($5) starting point taxation based willingness-to-pay algorithm. Results: The yearly incremental cost of providing robotic radiosurgery was $99,177. The mean community yearly willingness-to pay for robotic radiosurgery was $2,300,000, p=0.03. The calculated yearly net societal benefit for robotic radiosurgery was $2,200,823. Among participants who preferred robotic radiosurgery there was no evidence of starting point bias, p=0.8. Conclusions: We have shown through this pilot study that it is feasible to perform cost-benefit analysis to evaluate new technologies in Radiation Oncology. Cost-benefit analysis offers an analytic method to evaluate local preferences and provide accountability when allocating limited healthcare resources.


Sign in / Sign up

Export Citation Format

Share Document